 |
 |
 |
 |
 |
 |
 |
 |
 |
"Easton took an unusually active role in getting the Trellis Series A
financing done, and has contributed to the ongoing strategic planning at a level typically
not seen from venture capitalists, who have a habit of taking on too many responsibilities. While many
VC's talk about "value added" investing, the maturity and discipline that Easton has displayed makes the cliché come alive.
They understand that careful diligence going in is the key to a successful relationship.
There are risks in all investments, and an informed understanding of which are important
and which can be ignored is what entrepreneurs want from investors. Trellis is winning its
bets so far, and with a bit of luck we expect to give Easton a big payback."
Larry Kauvar
Founder and President, Trellis Bioscience
Trellis Bioscience
Trellis Bioscience has developed a breakthrough technology for drug development, which allows the direct assay of in vivo drug responses. This paradigm-shifting technology measures and analyzes protein translocation to determine whether critical protein pathways have been activated. It also provides novel drug targets. Trellis is based in SanFranciso, CA.